Cargando…
Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data
Bladder cancer (BLCA) is a common malignant cancer, and it is the most common genitourinary cancer in the world. The recurrence rate is the highest of all cancers, and the treatment of BLCA has only slightly improved over the past 30 years. Genetic and environmental factors play an important role in...
Autores principales: | Xu, Yingkun, Wu, Guangzhen, Li, Jianyi, Li, Jiatong, Ruan, Ningke, Ma, Liye, Han, Xiaoyang, Wei, Yanjun, Li, Liang, Zhang, Hongge, Chen, Yougen, Xia, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003274/ https://www.ncbi.nlm.nih.gov/pubmed/32047816 http://dx.doi.org/10.1155/2020/8283401 |
Ejemplares similares
-
Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma
por: Li, Jianyi, et al.
Publicado: (2020) -
Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
por: Xu, Yingkun, et al.
Publicado: (2020) -
Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer types
por: Wu, Guangzhen, et al.
Publicado: (2020) -
TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro
por: Xu, Yingkun, et al.
Publicado: (2020) -
Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)